See more : Innocean Worldwide Inc. (214320.KS) Income Statement Analysis – Financial Results
Complete financial analysis of The Cannabist Company Holdings Inc. (CBST.NE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of The Cannabist Company Holdings Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- XFit Brands, Inc. (XFTB) Income Statement Analysis – Financial Results
- Beiersdorf Aktiengesellschaft (BEI.DE) Income Statement Analysis – Financial Results
- Aerkomm Inc. (AKOM.PA) Income Statement Analysis – Financial Results
- Fortune Parts Industry Public Company Limited (FPI.BK) Income Statement Analysis – Financial Results
- China Putian Food Holding Limited (1699.HK) Income Statement Analysis – Financial Results
The Cannabist Company Holdings Inc. (CBST.NE)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.cannabistcompany.com
About The Cannabist Company Holdings Inc.
The Cannabist Company Holdings Inc. engages in the cultivation, manufacture, and provision of cannabis products and related services in the United States and internationally. The company offers spanning flower, edibles, oils, and tablets under the Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber brand names. It holds licenses in 17 jurisdictions in the United States. The company was formerly known as Columbia Care Inc. and changed its name to The Cannabist Company Holdings Inc. in September 2023. The company was founded in 2012 and is headquartered in New York, New York.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 511.33M | 491.31M | 456.03M | 188.99M | 79.26M | 347.78K |
| Cost of Revenue | 331.36M | 355.18M | 309.11M | 136.30M | 65.79M | 2.29M |
| Gross Profit | 179.97M | 136.13M | 146.92M | 52.68M | 13.47M | -1.94M |
| Gross Profit Ratio | 35.20% | 27.71% | 32.22% | 27.88% | 16.99% | -558.74% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 158.85M | 203.69M | 179.48M | 130.22M | 103.98M | 0.00 |
| Selling & Marketing | 5.39M | 14.17M | 16.26M | 6.08M | 5.79M | 0.00 |
| SG&A | 164.23M | 209.23M | 184.62M | 137.13M | 109.77M | 0.00 |
| Other Expenses | 120.98M | -3.04M | -1.33M | 368.00K | 0.00 | -807.59K |
| Operating Expenses | 285.21M | 209.23M | 184.62M | 137.13M | 109.77M | 807.59K |
| Cost & Expenses | 616.57M | 564.41M | 493.73M | 273.43M | 175.56M | 3.10M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 1.24M | 0.00 |
| Interest Expense | 54.87M | 53.90M | 30.01M | 6.34M | 0.00 | 0.00 |
| Depreciation & Amortization | 62.73M | 81.43M | 52.54M | 20.69M | 15.54M | 0.00 |
| EBITDA | -51.30M | -282.36M | -63.14M | -115.66M | -95.21M | -2.75M |
| EBITDA Ratio | -10.03% | 1.69% | 3.25% | -33.74% | -101.89% | -790.95% |
| Operating Income | -105.24M | -73.10M | -37.70M | -84.45M | -96.30M | -2.75M |
| Operating Income Ratio | -20.58% | -14.88% | -8.27% | -44.69% | -121.50% | -790.95% |
| Total Other Income/Expenses | -63.66M | -16.45M | -36.35M | -55.63M | 261.95K | 0.00 |
| Income Before Tax | -168.90M | -415.55M | -145.42M | -143.02M | -96.04M | -2.75M |
| Income Before Tax Ratio | -33.03% | -84.58% | -31.89% | -75.68% | -121.17% | -790.95% |
| Income Tax Expense | 5.39M | -10.77M | 137.78K | -17.05M | 13.17M | 0.00 |
| Net Income | -175.71M | -399.52M | -141.84M | -100.85M | -104.97M | -2.75M |
| Net Income Ratio | -34.36% | -81.32% | -31.10% | -53.36% | -132.44% | -790.95% |
| EPS | -0.44 | -1.02 | -0.42 | -0.43 | -0.50 | -0.01 |
| EPS Diluted | -0.44 | -1.02 | -0.42 | -0.43 | -0.50 | -0.01 |
| Weighted Avg Shares Out | 402.78M | 392.57M | 338.75M | 232.58M | 209.99M | 209.99M |
| Weighted Avg Shares Out (Dil) | 402.78M | 392.57M | 338.75M | 232.58M | 209.99M | 209.99M |
Source: https://incomestatements.info
Category: Stock Reports